Clinical Trial: Scleroderma Treatment With Celution Processed ADRCs Registry

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Observational [Patient Registry]




Official Title: Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (ADRCs) Registry

Brief Summary: This registry study will assess the safety and performance of the Celution Device in the processing of an autologous graft consisting of adipose derived regenerative cells (ADRCs) in the treatment of hand scleroderma.